Wedbush Securities’s Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda) CYTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-131
| Closed | -$49K | – | 1034 |
|
|
2020
Q2 | $49K | Buy |
+131
| New | +$49K | ﹤0.01% | 906 |
|
|
2020
Q1 | – | Sell |
-55
| Closed | -$36K | – | 1030 |
|
|
2019
Q4 | $36K | Buy |
+55
| New | +$36K | ﹤0.01% | 974 |
|
|
2019
Q3 | – | Sell |
-31
| Closed | -$35K | – | 1036 |
|
|
2019
Q2 | $35K | Buy |
31
+10
| +48% | +$11.3K | ﹤0.01% | 963 |
|
|
2019
Q1 | $59K | Buy |
+21
| New | +$59K | 0.01% | 888 |
|
|
2018
Q4 | – | Sell |
-19
| Closed | -$54K | – | 946 |
|
|
2018
Q3 | $54K | Buy |
19
+11
| +138% | +$31.3K | 0.01% | 869 |
|
|
2018
Q2 | $49K | Buy |
8
+5
| +167% | +$30.6K | 0.01% | 839 |
|
|
2018
Q1 | $33K | Buy |
3
+2
| +200% | +$22K | ﹤0.01% | 800 |
|
|
2017
Q4 | $26K | Hold |
1
| – | – | ﹤0.01% | 838 |
|
|
2017
Q3 | $36K | Hold |
1
| – | – | ﹤0.01% | 814 |
|
|
2017
Q2 | $32K | Hold |
1
| – | – | ﹤0.01% | 815 |
|
|
2017
Q1 | $41K | Buy |
+1
| New | +$41K | 0.01% | 810 |
|
|
2016
Q4 | – | Hold |
0
| – | -$30K | – | 805 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 806 |
|